Talis Biomedical Corp (TLIS)
9.20
0.00 (0.00%)
USD |
NASDAQ |
May 31, 16:00
9.21
+0.01
(+0.11%)
After-Hours: 20:00
Talis Biomedical Revenue (Quarterly): 0.073M for March 31, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.073M |
| December 31, 2023 | 0.151M |
| September 30, 2023 | 0.076M |
| June 30, 2023 | 0.048M |
| March 31, 2023 | 0.137M |
| Date | Value |
|---|---|
| December 31, 2022 | 0.107M |
| September 30, 2022 | 0.73M |
| June 30, 2022 | 0.502M |
| March 31, 2022 | 2.313M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
0.048M
Minimum
Jun 2023
2.313M
Maximum
Mar 2022
0.4597M
Average
0.137M
Median
Mar 2023
Revenue (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -- |
| Retractable Technologies Inc | 7.599M |
| Xtant Medical Holdings Inc | 27.87M |
| Asensus Surgical Inc | 1.123M |
| Catheter Precision Inc | 0.082M |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | -13.04M |
| Total Expenses (Quarterly) | 14.19M |
| EPS Diluted (Quarterly) | -7.15 |
| Enterprise Value | -53.57M |
| Gross Profit Margin (Quarterly) | 91.78% |
| Profit Margin (Quarterly) | -17.86K% |
| Earnings Yield | -341.6% |
| Normalized Earnings Yield | -341.63 |